ARYA Sciences Acquisition Corp IV

ARYD

KYG316591083

Investment Holding Companies

Market Closed - Nasdaq Other stock markets 21:30:00 13/05/2024 BST			5-day change	1st Jan Change
11.37 ^USD	+0.18%		+0.18%	+4.31%

03-29	ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Full Year Ended December 31, 2023	CI
02-08	ARYA Sciences Acquisition Corp IV announced that it has received $1 million in funding from ARYA Sciences Holdings IV	CI

ARYA Sciences Acquisition IV : New Financial Obligation - Form 8-K

October 03, 2023 at 01:49 pm

Item 2.03.

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement or a Registrant.

Attachments

Original Link
Original Document
Permalink

Disclaimer

ARYA Sciences Acquisition IV Corp. published this content on 02 October 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 October 2023 12:48:44 UTC.

Latest news about ARYA Sciences Acquisition Corp IV

ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Full Year Ended December 31, 2023	03-29	CI
ARYA Sciences Acquisition Corp IV announced that it has received $1 million in funding from ARYA Sciences Holdings IV	02-07	CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09	CI
ARYA Sciences Acquisition Corp IV announced that it has received $0.9 million in funding	26/09/23	CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11/08/23	CI
ARYA Sciences Acquisition Corp IV announced that it has received $0.14 million in funding from ARYA Sciences Holdings IV	01/06/23	CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23	CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Full Year Ended December 31, 2022	06/04/23	CI
ARYA Sciences Acquisition Corp IV Auditor Raises 'Going Concern' Doubt	05/04/23	CI
ARYA Sciences Acquisition Corp IV announced that it expects to receive $1.68 million in funding from ARYA Sciences Holdings IV	27/02/23	CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	07/11/22	CI
ARYA Sciences Acquisition Corp IV announced that it has received $0.12 million in funding from ARYA Sciences Holdings IV	06/11/22	CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	08/08/22	CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the First Quarter Ended March 31, 2022	13/05/22	CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Full Year Ended December 31, 2021	31/03/22	CI
ARYA Sciences Acquisition Corp IV Auditor Raises 'Going Concern' Doubt	30/03/22	CI
Amicus Therapeutics Loss Narrows, Revenue Rises in 2021; Terminates ARYA Sciences Combination Over Market Conditions	24/02/22	MT
Gene Therapy Business of Amicus Therapeutics, Inc. cancelled the acquisition of ARYA Sciences Acquisition Corp IV from Todd Wider, Leslie Trigg and Michael Henderson, ARYA Sciences Holdings IV and others in a reverse merger transaction.	22/02/22	CI
ARYA Sciences Acquisition Corp IV Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	12/11/21	CI
ARYA Sciences Acquisition Corp IV Provides Earnings Guidance for the Year 2021	09/11/21	CI
Editas Medicine : Health Care Stocks Easing Slightly From Intra-Day Highs Near Close	29/09/21	MT
Adagio Therapeutics : Health Care Stocks Recovering From Tuesday Selloff	29/09/21	MT
Amicus Therapeutics : Arya Sciences Acquisition Corp to Create Genetic Medicine Company Caritas Therapeutics	29/09/21	MT
ARYA Sciences Acquisition Corp IV announced that it expects to receive $201.5 million in funding from a group of investors	28/09/21	CI
Gene Therapy Business of Amicus Therapeutics, Inc. entered into a non-binding agreement to acquire ARYA Sciences Acquisition Corp IV from Todd Wider, Leslie Trigg and Michael Henderson, ARYA Sciences Holdings IV and others in a reverse merger transaction.	28/09/21	CI

Chart ARYA Sciences Acquisition Corp IV

Duration

Period

More charts

Company Profile

ARYA Sciences Acquisition Corp IV is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company is focused on healthcare or healthcare related industries. The Company has no operations and has not generated revenues.

Sector

Investment Holding Companies

More about the company

Income Statement Evolution

More financial data

Sector Shell Companies

	1st Jan change	Capi.
ARYA SCIENCES ACQUISITION CORP IV	+4.31%	89.98M
SCREAMING EAGLE ACQUISITION CORP.	-3.96%	1.04B
OKLO INC.	-7.48%	1.03B
CHURCHILL CAPITAL CORP VII	+2.10%	982M
APPLE ISPORTS GROUP, INC.	+41.91%	872M
PERELLA WEINBERG PARTNERS	+22.32%	814M
E7 GROUP	+8.62%	675M
ARES ACQUISITION CORPORATION II	+1.77%	664M
DA ZHONG TRADING GROUP HOLDING COMPANY	+0.00%	600M
ADMIRAL ACQUISITION LIMITED	+3.61%	503M